Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(20%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_3
1
20%
Ph phase_2
2
40%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
Phase 3Large-scale testing
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(2)
Other(2)

Detailed Status

unknown2
Completed2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (66.7%)
Phase 31 (33.3%)

Trials by Status

recruiting120%
unknown240%
completed240%

Recent Activity

1 active trials
Showing 5 of 5
recruiting

An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment

NCT06883240
completedphase_2

The Spot Sign for Predicting and Treating ICH Growth Study

NCT00810888
completed

Thrombin Generation in Neonatal Plasma After Cardiopulmonary Bypass

NCT01352143
unknownphase_2

rFVIIa Prophylaxis in Children With Hemophilia A and Inhibitors

NCT01105546
unknownphase_3

"Salvage Use" of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac Surgery

NCT00214656

Clinical Trials (5)

Showing 5 of 5 trials
NCT06883240

An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment

Recruiting
NCT00810888Phase 2

The Spot Sign for Predicting and Treating ICH Growth Study

Completed
NCT01352143

Thrombin Generation in Neonatal Plasma After Cardiopulmonary Bypass

Completed
NCT01105546Phase 2

rFVIIa Prophylaxis in Children With Hemophilia A and Inhibitors

Unknown
NCT00214656Phase 3

"Salvage Use" of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac Surgery

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5